Abstract
Background
Chronic liver disease (CLD) is among the strongest risk factors for adverse prescription opioid-related events. Yet, the current prevalence and factors associated with high-risk opioid prescribing in patients with chronic liver disease (CLD) remain unclear, making it challenging to address opioid safety in this population. Therefore, we aimed to characterize opioid prescribing patterns among patients with CLD.
Methods
This retrospective cohort study included patients with CLD identified at a single medical center and followed for one year from 10/1/2015-9/30/2016. Multivariable, multinomial regression was used identify the patient characteristics, including demographics, medical conditions, and liver-related factors, that were associated with opioid prescriptions and high-risk prescriptions (≥90mg morphine equivalents per day [MME/day] or co-prescribed with benzodiazepines).
Results
Nearly half (47%) of 12,425 patients with CLD were prescribed opioids over a one-year period, with 17% of these receiving high-risk prescriptions. The baseline factors significantly associated with high-risk opioid prescriptions included female gender (adjusted incident rate ratio, AIRR = 1.32, 95% CI = 1.14–1.53), Medicaid insurance (AIRR = 1.68, 95% CI = 1.36–2.06), cirrhosis (AIRR = 1.22, 95% CI = 1.04–1.43) and baseline chronic pain (AIRR = 3.40, 95% CI = 2.94–4.01), depression (AIRR = 1.93, 95% CI = 1.60–2.32), anxiety (AIRR = 1.84, 95% CI = 1.53–2.22), substance use disorder (AIRR = 2.16, 95% CI = 1.67–2.79), and Charlson comorbidity score (AIRR = 1.27, 95% CI = 1.22–1.32). Non-alcoholic fatty liver disease was associated with decreased high-risk opioid prescriptions (AIRR = 0.56, 95% CI = 0.47–0.66).
Conclusion
Opioid medications continue to be prescribed to nearly half of patients with CLD, despite efforts to curtail opioid prescribing due to known adverse events in this population.
Funder
agency for healthcare research and quality
national institute on drug abuse
Publisher
Public Library of Science (PLoS)
Reference56 articles.
1. Centers for Disease Control and Prevention. Prescribing Practices | Drug Overdose | CDC Injury Center. November 18, 2020]; Available from: https://www.cdc.gov/drugoverdose/data/prescribing/prescribing-practices.html.
2. National Center for Health Statistics (US). Health, United States, 2018 –Data Finder. November 18, 2020]; Available from: https://www.cdc.gov/nchs/hus/contents2018.htm.
3. Psychoactive substance use prior to the development of iatrogenic opioid abuse: A descriptive analysis of treatment-seeking opioid abusers;T.J. Cicero;Addict Behav,2017
4. Characteristics of Opioid Prescriptions to Veterans With Cirrhosis;S.S. Rogal;Clin Gastroenterol Hepatol,2019
5. Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of patients with compensated cirrhosis;A.M. Moon;Aliment Pharmacol Ther,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hepatic Encephalopathy;Clinics in Liver Disease;2024-02
2. Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy;Clinical Gastroenterology and Hepatology;2022-08